Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2020 Apr 1;29(12):2495–2503. doi: 10.1158/1055-9965.EPI-20-0005

Table 1.

Populations recommended for surveillance for hepatocellular carcinoma

Population Annual Incidence
Cirrhosis of any etiology 1%-8%
Asian males with chronic hepatitis B ≥ 40 years of age 0.4%-0.6%
Asian females with chronic hepatitis B ≥ 50 years of age 0.3%-0.6%
African patients and North American blacks with chronic hepatitis B ≥ 20 years of age 0.3%-0.6%